Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | OT |
She also reported having mild vertigo starting 6/21/2025.; started experiencing moderate breast and back pain on 6/15/2025 on the same side that she received the vaccine.; started experiencing moderate breast and back pain on 6/15/2025 on the same side that she received the vaccine.; This spontaneous report was received from physician and refers to a 60-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-Jun-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) administered by intramuscular route for immunization (dose, lot #, expiration date and anatomical site of injection were not reported). On 15-Jun-2025, the patient experienced moderate breast and back pain on the same side where the vaccine was administered. On 21-Jun-2025, she experienced mild vertigo. At the reporting time, the patient was recovering from the events of breast pain, back pain and vertigo. The patient was treated with Celebrex. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine was not provided. No additional information was provided.